Astrana Health, Inc. (ASTH)

NASDAQ: ASTH · Real-Time Price · USD

37.55

+1.68 (4.68%)

At close: Oct 9, 2026, 4:00 PM EDT

37.01

-0.54 (-1.44%)

After-hours: Oct 9, 2026, 7:30 PM EDT

Astrana Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,922	1,244	1,549	1,706	1,348	3,279
Market Cap Growth	11.55%	-19.65%	-9.23%	26.59%	-58.90%	387.82%
Enterprise Value	2,500	1,647	1,477	1,687	1,396	3,242
Last Close Price	37.55	24.81	31.53	38.30	29.59	73.48

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	45.80	55.34	35.89	28.10	29.84	47.57
Forward PE	22.28	29.95	25.02	30.62	65.76	63.35
PS Ratio	0.50	0.39	0.76	1.23	1.18	4.24
PB Ratio	2.23	2.23	3.01	4.15	2.41	6.42
P/TBV Ratio	-	-	8.84	6.47	6.85	27.57
P/FCF Ratio	20.36	11.91	35.07	42.98	22.77	64.15
P/OCF Ratio	17.81	10.86	29.67	25.01	16.41	46.62
PEG Ratio	-	0.89	1.36	2.14	1.49	2.50

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	0.65	0.52	0.73	1.22	1.22	4.19
EV/EBITDA Ratio	14.29	11.45	12.59	16.48	11.46	28.03
EV/EBIT Ratio	22.35	16.79	16.53	19.93	13.39	33.03
EV/FCF Ratio	26.49	15.77	33.44	42.49	23.59	63.44

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	1.64	1.93	0.92	0.78	0.41	0.40
Debt / EBITDA Ratio	5.09	6.79	3.59	2.92	1.79	1.67
Debt / FCF Ratio	10.38	10.32	10.66	8.09	3.88	3.95
Net Debt / Equity Ratio	0.97	1.16	0.35	0.06	-0.11	-0.16
Net Debt / EBITDA Ratio	3.31	4.51	1.53	0.24	-0.53	-0.73
Net Debt / FCF Ratio	6.13	6.21	4.07	0.63	-1.08	-1.65
Asset Turnover	2.06	1.78	1.78	1.46	1.25	0.92
Quick Ratio	1.19	1.35	1.68	2.03	2.76	3.33
Current Ratio	1.23	1.40	1.75	2.11	2.88	3.53
Return on Equity (ROE)	6.90%	4.49%	10.80%	11.94%	8.56%	9.64%
Return on Assets (ROA)	3.75%	3.43%	4.88%	5.57%	7.11%	7.28%
Return on Invested Capital (ROIC)	6.24%	6.28%	9.77%	11.72%	11.96%	13.36%
Return on Capital Employed (ROCE)	7.30%	6.10%	9.00%	11.80%	12.80%	13.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.11%	1.81%	2.79%	3.56%	3.35%	2.10%
FCF Yield	4.91%	8.40%	2.85%	2.33%	4.39%	1.56%
Payout Ratio	-	35.07%	-	102.24%	31.06%	45.11%
Buyback Yield / Dilution	-1.73%	-2.91%	-2.20%	-2.94%	-0.44%	-21.24%

SEC Filings: 10-K · 10-Q